Полезная еда

1. Vogel R. A., Corretti M. C., Plotnick G. D. Effect of a Single High-Fat Meal on Endothelial Function in Healthy Subjects // American Journal of Cardiology. 1997, February 1. Vol. 79, N. 3. P. 350–354.

2. Hitti M. FDA Approves New Angina Drug: Ranexa Is for Patients Who Haven’t Responded to Other Chest Pain Drugs // WebMD. 2006. February 7 // http://www.webmd.com/heart-disease/news/20060207/fda-approves-new-angina-drug.

3. Waters J. The History of American Ginseng. По состоянию на 10 ноября 2012 года // http://www.telliquah.com/Ginseng/Ginseng.htm.

4. Morrison L. M. Arteriosclerosis: Recent Advances in the Dietary and Medicinal Treatment // Journal of the American Medical Association. 1951. Vol. 145, N. 16. P. 1232–1236; Morrison L. M. Diet in Coronary Atherosclerosis // Journal of the American Medical Association. 1960. Vol. 173, N. 8. P. 884–888.

5. Pritikin N., McGrady P. M. The Pritikin Program for Diet and Exercise. Bantam Books, 1984. P. 438.

6. Esselstyn C. B. Jr. Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven, Nutrition-Based Cure. New York: Avery Trade, 2008; Esselstyn C. B. Jr., Ellis S. G., Medendorp S. V., Crowe T. D. A Strategy to Arrest and Reverse Coronary Artery Disease: A 5-Year Longitudinal Study of a Single Physician’s Practice // Journal of Family Practice, 1995. Vol. 41, N. 6. P. 560–568.

7. Ornish D. Eat More, Weigh Less. New York: HarperCollins, 1993; Ornish D., Brown S. E., Scherwitz L. W. et al. Can Lifestyle Changes Reverse Coronary Heart Disease? // Lancet. 1990. Vol. 336, No. 8708. P. 129–133.

8. Esselstyn et al. A Strategy to Arrest and Reverse.

9. Esselstyn C. B. Jr. Updating a 12-year Experience with Arrest and Reversal Therapy for Coronary Heart Disease (An Overdue Requiem for Palliative Cardiology) // American Journal of Cardiology. 1999. Vol. 84. P. 339–341.

10. Hitti M. FDA Approves New Angina Drug: Ranexa Is for Patients Who Haven’t Responded to Other Chest Pain Drugs // WebMD. 2006 February 7// http://www.webmd.com/heart-disease/news/20060207/fda-approves-new-angina-drug.

11. Точное число необходимых

экспериментальных точек вы найдете в приложении к любому серьезному учебнику статистики. Здесь главное, что исследование Эссельстина с глубокими результатами можно было провести с небольшим числом участников, а испытания большинства лекарств — нет.

Глава 3

1. Madhavan T. V., Gopalan C. The Effect of Dietary Protein on Carcinogenesis of Aflatoxin // Archives of Pathology. 1968, February. Vol. 85, N. 2. P. 133–137.

2. Mulder G. J. On the Composition of Some Animal Substances // Journal für praktische Chemie, 1839. Vol. 16. P. 129–152 (статья, в которой он упомянул белок, согласно Munro H. N. Mammalian protein metabolism. Vol. I / H. N. Munro and J. B. Allison (eds.). Academic Press, 1964. P. 1–29). Mulder G. J. The Chemistry of Vegetable & Animal Physiology, trans. P. F. H. Fromberg, W. Blackwood & Sons. Edinburgh, Scotland, 1849.

3. Schulsinger D. A., Root M. M., Campbell T. C. Effect of Dietary Protein Quality on Development of Aflatoxin B1-Induced Hepatic Preneoplastic Lesions // Journal of the National Cancer Institute, 1989. Vol. 81. P. 1241–1245.

4. Youngman L. D. Recall, Memory, Persistence, and the Sequential Modulation of Preneoplastic Lesion Development by Dietary Protein. Cornell University, 1987. Masters Thesis (T. C. Campbell, Mentor).

5. Dunaif G. E., Campbell T. C. Relative Contribution of Dietary Protein Level and Aflatoxin B1 Dose in Generation of Presumptive Preneoplastic Foci in Rat Liver // Journal of the National Cancer Institute, 1987. Vol. 78. P. 365–369; Youngman L. D., Campbell T. C. Inhibition of Aflatoxin B1-Induced Gamma-Glutamyl Transpeptidase Positive (GGT⁺) Hepatic Preneoplastic Foci and Tumors by Low Protein Diets: Evidence That Altered GGT⁺ Foci Indicate Neoplastic Potential // Carcinogenesis, 1992. Vol. 13, N. 9. P. 1607–1613.

6. Chen J., Campbell T. C., Li J., Peto R. Diet, Life-Style and Mortality in China. A study of the characteristics of 65 Chinese counties. Oxford, United Kingdom; Ithaca, NY; and Beijing, People’s Republic of China: Oxford University Press, Cornell University Press, and People’s Medical Publishing House, 1990.

7. Muldoon M. F., Manuck S. B., Matthews K. A. Lowering Cholesterol Concentrations and Mortality: A Quantitative Review of Primary Prevention Trials // BMJ, 1990. Vol. 301, N. 6747. P. 309–314.

8. Stemmermann G. N., Nomura A. M., Heilbrun L. K. et al. Serum Choles­terol and Colon Cancer Incidence in Hawaiian Japanese Men // Journal of the National Cancer Institute, 1981. Vol. 67, N. 6. P. 1179–1182.

9. Madhavan T. V., Gopalan C. The Effect of Dietary Protein on Carcino­genesis of Aflatoxin // Archives of Pathology, 1968, February. Vol. 85, N. 2. P. 133–137.

10. Madhavan T. V., Gopalan C. Effect of Dietary Protein on Aflatoxin Liver Injury in Weanling Rats // Archives of Pathology, 1965, August. Vol. 80. P. 123–126.

Часть II

Глава 4